Without TV ads, restless legs may take a hike
Generic drugs could lead to less hype over ‘jimmy legs’ syndrome
After a speedy rise as one of the nation’s oddest-sounding designer disorders, restless legs syndrome may have run its course.In 2005, the federal Food and Drug Administration approved the first medication targeting the twitching condition, propelling the problem to household-name status and launching a multimillion-dollar consumer advertising campaign by manufacturer GlaxoSmithKline.
For further joyness, please read on!!!